1. Home >
  2. BICO Acquires Advanced BioMatrix

M&A Deal Summary

BICO Acquires Advanced BioMatrix

On August 27, 2021, BICO acquired life science company Advanced BioMatrix for 15M USD

Acquisition Highlights
  • This is BICO’s 1st transaction in the Life Science sector.
  • This is BICO’s 2nd largest (disclosed) transaction.
  • This is BICO’s 1st transaction in the United States.
  • This is BICO’s 1st transaction in California.

M&A Deal Summary
Date 2021-08-27
Target Advanced BioMatrix
Sector Life Science
Buyer(s) BICO
Deal Type Add-on Acquisition
Deal Value 15M USD

Target

Advanced BioMatrix

Carlsbad, California, United States
Advanced BioMatrix is an American company focusing on 3D research applications. The Advanced BioMatrix portfolio includes collagen bioinks, high purity extracellular matrix proteins, chemically modified proteins, and polysaccharides, and other reagents and cell assays, sold to research institutions, and pharmaceutical and biotech companies. Advanced BioMatrix was founded in 2008 and is based in Carlsbad, California.

Search 204,883 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BICO

Gothenburg, Sweden
Category Company
Founded 2016
Sector Life Science
Employees832
Revenue 2.3B SEK (2023)
DESCRIPTION

BICO is a bio convergence company that combines different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology. With a focus on the application areas of bioprinting, multi-omics, cell line development, and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. BICO was founded in 2016 and is based in Gothenburg, Sweden.

DEAL STATS #
Overall 1 of 3
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 3
State (California) 1 of 1
Country (United States) 1 of 2
Year (2021) 1 of 3
Size (of disclosed) 2 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-15 Hurel

North Brunswick Township, New Jersey, United States

Hurel uses cell biology and microfluidics in a “chip” to help drug companies predict pre-clinically the drug candidates with the best chances of winning FDA approval. Hurel was founded in 2005 and is based in North Brunswick Township, New jersey.

Buy -
Mergr

Product

Company

Legal